Literature DB >> 9869633

Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis.

Q Xiao1, G Claassen, J Shi, S Adachi, J Sedivy, S R Hann.   

Abstract

Transcriptional activation by c-Myc through specific E box elements is thought to be essential for its biological role. However, c-MycS is unable to activate transcription through these elements and yet retains the ability to stimulate proliferation, induce anchorage-independent growth, and induce apoptosis. In addition, c-MycS retains the ability to repress transcription of several specific promoters. Furthermore, c-MycS can rescue the c-myc null phenotype in fibroblasts with homozygous deletion of c-myc. Taken together, our data argue against the paradigm that all of the biological functions of c-Myc are mediated by transcriptional activation of specific target genes through E box elements.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869633      PMCID: PMC317265          DOI: 10.1101/gad.12.24.3803

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  21 in total

1.  Translational activation of the non-AUG-initiated c-myc 1 protein at high cell densities due to methionine deprivation.

Authors:  S R Hann; K Sloan-Brown; G D Spotts
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

2.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.

Authors:  F Kohlhuber; H Hermeking; A Graessmann; D Eick
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

4.  c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.

Authors:  D Reisman; N B Elkind; B Roy; J Beamon; V Rotter
Journal:  Cell Growth Differ       Date:  1993-02

5.  The ornithine decarboxylase gene is a transcriptional target of c-Myc.

Authors:  C Bello-Fernandez; G Packham; J L Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  Myc and Max proteins possess distinct transcriptional activities.

Authors:  L Kretzner; E M Blackwood; R N Eisenman
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

7.  Definition of regions in human c-myc that are involved in transformation and nuclear localization.

Authors:  J Stone; T de Lange; G Ramsay; E Jakobovits; J M Bishop; H Varmus; W Lee
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

8.  The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.

Authors:  S R Hann; M Dixit; R C Sears; L Sealy
Journal:  Genes Dev       Date:  1994-10-15       Impact factor: 11.361

9.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

10.  c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

Authors:  L H Li; C Nerlov; G Prendergast; D MacGregor; E B Ziff
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  35 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.

Authors:  C Bouchard; O Dittrich; A Kiermaier; K Dohmann; A Menkel; M Eilers; B Lüscher
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

5.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

Authors:  A L Gartel; X Ye; E Goufman; P Shianov; N Hay; F Najmabadi; A L Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

6.  mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network.

Authors:  Hyoungsoo Choi; Nateka L Jackson; Denise R Shaw; Peter D Emanuel; Y Lucy Liu; Albert Tousson; Zheng Meng; Scott W Blume
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

7.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.

Authors:  A Bush; M Mateyak; K Dugan; A Obaya; S Adachi; J Sedivy; M Cole
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

8.  Transactivation Domain of Human c-Myc Is Essential to Alleviate Poly(Q)-Mediated Neurotoxicity in Drosophila Disease Models.

Authors:  Kritika Raj; Surajit Sarkar
Journal:  J Mol Neurosci       Date:  2017-03-18       Impact factor: 3.444

9.  Wnt activation and alternative promoter repression of LEF1 in colon cancer.

Authors:  Tony W-H Li; Ju-Hui T Ting; Noriko N Yokoyama; Alla Bernstein; Marc van de Wetering; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

10.  Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Authors:  N Bardeesy; B C Bastian; A Hezel; D Pinkel; R A DePinho; L Chin
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.